O'Callaghan JP - Search Results

1

Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.

Gordon MN, Holcomb LA, Jantzen PT, DiCarlo G, Wilcock D, Boyett KW, Connor K, Melachrino J, O'Callaghan JP, Morgan D. Gordon MN, et al. Exp Neurol. 2002 Feb;173(2):183-95. doi: 10.1006/exnr.2001.7754. Exp Neurol. 2002. PMID: 11822882

2

Long-term induction of Fos-related antigen-2 after methamphetamine-, methylenedioxymethamphetamine-, 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine- and trimethyltin-induced brain injury.

Pennypacker KR, Yang X, Gordon MN, Benkovic S, Miller D, O'Callaghan JP. Pennypacker KR, et al. Neuroscience. 2000;101(4):913-9. doi: 10.1016/s0306-4522(00)00381-x. Neuroscience. 2000. PMID: 11113340

3

The effect of age and testosterone on the expression of glial fibrillary acidic protein in the rat cerebellum.

Day JR, Frank AT, O'Callaghan JP, Jones BC, Anderson JE. Day JR, et al. Exp Neurol. 1998 Jun;151(2):343-6. doi: 10.1006/exnr.1998.6801. Exp Neurol. 1998. PMID: 9628769

4

Brain injury: prolonged induction of transcription factors.

Pennypacker KR, Kassed CA, Eidizadeh S, O'Callaghan JP. Pennypacker KR, et al. Acta Neurobiol Exp (Wars). 2000;60(4):515-30. doi: 10.55782/ane-2000-1373. Acta Neurobiol Exp (Wars). 2000. PMID: 11200181 Free article. Review.

5

SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.

Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O'Callaghan JP, Huber JD, Matsumoto RR. Robson MJ, et al. Exp Neurol. 2014 Apr;254:180-9. doi: 10.1016/j.expneurol.2014.01.020. Epub 2014 Feb 6. Exp Neurol. 2014. PMID: 24508558 Free PMC article.

6

Increased glial fibrillary acidic protein (GFAP) levels in the brains of transgenic mice expressing the bovine growth hormone (bGH) gene.

Miller DB, Bartke A, O'Callaghan JP. Miller DB, et al. Exp Gerontol. 1995 May-Aug;30(3-4):383-400. doi: 10.1016/0531-5565(94)00064-a. Exp Gerontol. 1995. PMID: 7556516

7

Immunohistochemical localization and quantification of glial fibrillary acidic protein and synaptosomal-associated protein (mol. wt 25000) in the ageing hippocampus following administration of 5,7-dihydroxytryptamine.

Dugar A, Patanow C, O'Callaghan JP, Lakoski JM. Dugar A, et al. Neuroscience. 1998 Jul;85(1):123-33. doi: 10.1016/s0306-4522(97)00606-4. Neuroscience. 1998. PMID: 9607708

8

Quantification of regional glial fibrillary acidic protein levels in Alzheimer's disease.

Ross GW, O'Callaghan JP, Sharp DS, Petrovitch H, Miller DB, Abbott RD, Nelson J, Launer LJ, Foley DJ, Burchfiel CM, Hardman J, White LR. Ross GW, et al. Acta Neurol Scand. 2003 May;107(5):318-23. doi: 10.1034/j.1600-0404.2003.02098.x. Acta Neurol Scand. 2003. PMID: 12713522

9

Population variation in glial fibrillary acidic protein levels in brain ageing: relationship to Alzheimer-type pathology and dementia.

Wharton SB, O'Callaghan JP, Savva GM, Nicoll JA, Matthews F, Simpson JE, Forster G, Shaw PJ, Brayne C, Ince PG; MRC Cognitive Function and Ageing Neuropathology Study Group. Wharton SB, et al. Dement Geriatr Cogn Disord. 2009;27(5):465-73. doi: 10.1159/000217729. Epub 2009 May 7. Dement Geriatr Cogn Disord. 2009. PMID: 19420941

10

Laping NJ, Teter B, Anderson CP, Osterburg HH, O'Callaghan JP, Johnson SA, Finch CE. Laping NJ, et al. J Neurosci Res. 1994 Dec 15;39(6):710-7. doi: 10.1002/jnr.490390612. J Neurosci Res. 1994. PMID: 7897706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters